BioSpace News Archive

Hyundai Hope On Wheels embarks on a nationwide tour in honor of National Childhood Cancer Awareness Month.

Organogenesis Inc., a global leader in regenerative medicine with headquarters in Canton, Mass., today announced the winner of its 2018 Canton High School Regenerative Medicine Scholarship Award.

PPG (NYSE:PPG) today announced that the PPG Foundation recently invested nearly $150,000 in 23 northern Ohio organizations in support of educational and community sustainability programs.

Staying committed to healthy habits can be daunting. We are constantly faced with tradeoffs. Cooking at home versus indulging in a night out.

Bolder BioTechnology, Inc. announced today that Dr. Joe Cox, Company President, gave an oral presentation at the “Growth Factors and Other Cytokines for Treatment of Injuries During a Radiation Public Health Emergency” meeting held August 30, 2018 at the National Institute of Allergy and Infectious Diseases Conference Center, 5601 Fishers Lane, Rockville, Maryland.

Children’s Health joins forces with PM Pediatrics to open first Children’s Health PM Urgent Care practice

Leviticus Cardio announces the successful completion of a 90-day preclinical chronic animal study to evaluate its CET technology in combination with a commercial heart pump.

oung researchers produce the discoveries and innovations that help build a strong future for Canada, one that includes a clean environment, healthy communities and a growing middle class. That is why the Government of Canada is investing to support their greatest research ambitions

Life Fitness, the global leader in commercial fitness equipment, today announced that Marie Graul has joined the Company as its chief financial officer, reporting to Jaime Irick, President – Life Fitness.

Accreditation Council for Medical Affairs, a self-governing, independent organization which promotes standards of excellence around both core technical competencies and ethical practices for pharmaceutical industry professionals in medical affairs has appointed Dr. Charles Stacey, President and CEO of Accera Pharmaceuticals to its Board of Governors.